We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$61.5B
1-Year Est. Return
30.7%
This Fund
S&P 500
This Quarter
Est. Return
+5%
1 Year Est. Return
+30.7%
3 Year Est. Return
+96.89%
5 Year Est. Return
+121.97%
10 Year Est. Return
+542.41%
AUM
$40.3B
AUM Growth
+$535M
(+1.3%)
Cap. Flow
-$468M
Cap. Flow
% of AUM
-1.16%
Top 10 Holdings %
Top 10 Hldgs %
15.78%
Holding
2,279
New
170
Increased
711
Reduced
1,071
Closed
189
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$178M |
| 2 |
LyondellBasell Industries
LYB
|
+$133M |
| 3 |
AT&T
T
|
+$124M |
| 4 |
Stanley Black & Decker
SWK
|
+$101M |
| 5 |
Pfizer
PFE
|
+$93.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$229M |
| 2 |
Gilead Sciences
GILD
|
+$164M |
| 3 |
Broadcom
AVGO
|
+$149M |
| 4 |
KeyCorp
KEY
|
+$145M |
| 5 |
Darden Restaurants
DRI
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.21% |
| 2 | Technology | 14.44% |
| 3 | Financials | 10.84% |
| 4 | Industrials | 8.99% |
| 5 | Consumer Discretionary | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
Stanley Black & Decker
SWK
$14.3B
| $159M | 0.4% |
1,699,234
+1,223,715
| +257% | +$101M |
|
52
Best Buy
BBY
$19.1B
| $156M | 0.39% |
1,898,886
+178,702
| +10% | +$13.3M |
|
53
Xylem
XYL
$28.9B
| $150M | 0.37% |
1,330,225
+561,597
| +73% | +$59.4M |
|
54
Travelers Companies
TRV
$82.5B
| $144M | 0.36% |
827,269
+6,261
| +0.8% | +$1.1M |
|
55
Unilever
UL
$143B
| $139M | 0.35% |
2,371,607
+357,783
| +18% | +$21.2M |
|
56
Sanofi
SNY
$109B
| $138M | 0.34% |
2,568,568
+466,819
| +22% | +$25.1M |
|
57
Fortune Brands Innovations
FBIN
$5.8B
| $138M | 0.34% |
1,922,685
+87,076
| +5% | +$5.54M |
|
58
Arcturus Therapeutics
ARCT
$161M
| $137M | 0.34% |
4,778,500
| – | – |
|
59
Abbott
ABT
$191B
| $134M | 0.33% |
1,229,415
-93,507
| -7% | -$9.97M |
|
60
Legend Biotech
LEGN
$3.66B
| $134M | 0.33% |
1,941,516
-397,284
| -17% | -$26M |
|
61
Alibaba
BABA
$276B
| $133M | 0.33% |
1,598,209
+238,705
| +18% | +$20.9M |
|
62
ServiceNow
NOW
$119B
| $133M | 0.33% |
1,183,270
+147,805
| +14% | +$14.8M |
|
63
Walt Disney
DIS
$172B
| $131M | 0.33% |
1,466,443
+27,766
| +2% | +$2.63M |
|
64
argenx
ARGX
$55.2B
| $130M | 0.32% |
334,223
-11,991
| -3% | -$4.72M |
|
65
Quanta Services
PWR
$83.9B
| $128M | 0.32% |
652,706
+190,227
| +41% | +$33.2M |
|
66
Hamilton Lane
HLNE
$3.86B
| $127M | 0.31% |
1,584,700
| – | – |
|
67
Newmont
NEM
$94.2B
| $125M | 0.31% |
2,927,378
+651,775
| +29% | +$29.6M |
|
68
NextEra Energy
NEE
$186B
| $124M | 0.31% |
1,674,064
-51,973
| -3% | -$3.93M |
|
69
Johnson & Johnson
JNJ
$646B
| $123M | 0.31% |
743,223
+5,194
| +0.7% | +$838K |
|
70
Inspire Medical Systems
INSP
$1.48B
| $122M | 0.3% |
376,554
+33,654
| +10% | +$9.62M |
|
71
Evergy
EVRG
$19.6B
| $121M | 0.3% |
2,078,034
+9,913
| +0.5% | +$599K |
|
72
British American Tobacco
BTI
$136B
| $120M | 0.3% |
3,607,149
-3,303,897
| -48% | -$113M |
|
73
Procter & Gamble
PG
$338B
| $118M | 0.29% |
778,520
+30,287
| +4% | +$4.56M |
|
74
S&P Global
SPGI
$123B
| $113M | 0.28% |
282,360
-48,958
| -15% | -$17.9M |
|
75
Zoetis
ZTS
$33B
| $113M | 0.28% |
655,696
+17,504
| +3% | +$3.03M |
|
Similar funds
Federated Hermes's Q2 2023 Portfolio in Review
As of Q2 2023, Federated Hermes held 2,279 positions worth $40.3B, up 1.3% from $39.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2023 filing shows 170 new, 711 increased, 1,071 reduced and 189 closed positions. Its largest new stake was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M. The largest sale was Clorox, an estimated $229M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q2 2023 buy was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M.
- Federated Hermes added most to Amgen in Q2 2023, an estimated $178M increase.
- Federated Hermes's biggest Q2 2023 reduction was Clorox, cutting an estimated $229M.
- Federated Hermes fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $55.4M.
- Federated Hermes's ten largest holdings make up 16% of its $40.3B portfolio in Q2 2023.
- Federated Hermes opened 170 new positions and closed 189 in Q2 2023.
- Federated Hermes's portfolio value rose 1.3% quarter-over-quarter to $40.3B.
Based on Federated Hermes's 13F filing for Q2 2023, filed 14 Aug 2023.